- Industry scrambles to defuse row over "satanic" campaign against South African IP plans
- M&A, patents & pricing, tech invasion may define Indian pharma in 2014
- Pfizer fights back on Indian 'anti-patent' system
- Patent 'mischief' lurks after Myriad
COMMENT Other Informa Comment
- INTERVIEW: Dr Reddy's CEO on the 'windshield and rear view mirror'
- Hengrui: China's innovation injection